Page 2 - Adele Gulfo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adele gulfo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adele Gulfo Today - Breaking & Trending Today

Sumitomo Pharma America Launches as New Combined Organization with Expanded Scale, Resources & Capabilities

/PRNewswire/ Sumitomo Pharma America, Inc. (SMPA), as previously announced on April 3, 2023, is pleased to share it has successfully launched its operations. ....

United Kingdom , Sumitomo Pharma , Myrtle Potter , Hiroshi Nomura , Maya Frutiger , Armin Szegedi , Adele Gulfo , Sumitomo Pharma America , Jatin Shah , Prnewswire Sumitomo Pharma America Inc , Sumitomo Pharma America Inc , A Sumitomo Pharma Group , Mission As , Sumitomo Pharma Co Ltd , Oncology Development , Head Of Corporate Communications , Officers Of Sumitomo Pharma Co Ltd , Pharma America , Chief Executive Officer , Chief Medical Officer , Executive Officers , Growth Engine , Representative Director , Sumitomo Pharma Group , North America , Biopharma Commercial ,

Myovant Sciences Ltd. (MYOV) Q4 2020 Earnings Call Transcript

MYOV earnings call for the period ending March 31, 2021. ....

Sumitomo Dainippon Pharma , Adele Gulfo , Roy Buchanan , Lauren Merendino , Phil Nadeau Cowen , Jason Butler , Bryan Crowe , Frank Karbe , Paul Choi Goldman Sachs , Juan Camilo Arjona , Brian Skorney , Paul Choi , Dave Marek , Mohit Bansal Citi , Phil Nadeau , Deric Joseph , Mohit Bansal , Myovant Sciences , European Commission , Goldman Sachs , Gedeon Richter , Opt Committee , Myovant Sciences Ltd , Company Analyst , New England Journal , Chief Financial ,

Myovant Sciences Appoints Lauren Merendino as Chief Commercial Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Myovant Sciences Appoints Lauren Merendino as Chief Commercial Officer
Myovant Sciences, Inc.April 5, 2021 GMT
BASEL, Switzerland, April 05, 2021 (GLOBE NEWSWIRE) Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced the appointment of Lauren Merendino as Chief Commercial Officer of Myovant Sciences, Inc., effective April 5, 2021. Ms. Merendino brings over 20 years of pharmaceutical and biotech leadership experience to Myovant, with expertise in building and leading commercial teams accompanied by a record of successful product launches. She most recently served as Vice President, Neurological Rare Diseases at Genentech. Ms. Merendino will be a member of Myovant’s Executive Committee, reporting directly to Chief Executive Officer David Marek. ....

David Marek , Albert Liao , Adele Gulfo , Bryan Crowe , Myovant Sciences , Myovant Sciences Inc , Corporate Communications , Sumitomo Dainippon Pharma Co Ltd , Sumitovant Biopharma Ltd , Myovant Executive Committee , Lauren Merendino , Chief Commercial Officer , Vice President , Neurological Rare Diseases , Executive Committee , Chief Executive Officer David , Sumitovant Biopharma , Investor Relations , டேவிட் மரேக் , ஆல்பர்ட் லியாவோ , ரியான் காகம் , பெருநிறுவன தகவல்தொடர்புகள் , தலைமை வணிகரீதியானது அதிகாரி , துணை ப்ரெஸிடெஂட் , நரம்பியல் ரேர் நோய்கள் , நிர்வாகி குழு ,

Myovant Sciences Ltd. (MYOV) Q3 2020 Earnings Call Transcript

Operator
Good day, everyone, and welcome to Myovant Sciences third quarter of fiscal-year 2020 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Please go ahead.
Ryan Crowe
Vice President, Investor Relations
Thank you, operator. Good morning, and thanks for joining us today for a general business update and to review the financial results of Myovant s third quarter of fiscal-year 2020. Joining me for today s call are Dave Marek, Myovant s chief executive officer, Frank Karbe, president and chief financial officer; Adele Gulfo, interim chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer. ....

United States , Frank Karbe , Adele Gulfo , Bryan Crowe , Dave Marek , Juan Camilo , Juan Camilo Arjona , Myovant Sciences Ltd , Myovant Sciences , Investor Relations , Adding Pfizer , ஒன்றுபட்டது மாநிலங்களில் , ரியான் காகம் , டேவ் மரேக் , ஜுவான் கேமிலோ , முதலீட்டாளர் உறவுகள் ,